Lensar, Inc. LNSR
We take great care to ensure that the data presented and summarized in this overview for LENSAR, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding LNSR
View all-
North Run Capital, LP Wellesley, MA1.1MShares$4.59 Million7.54% of portfolio
-
Park West Asset Management LLC Larkspur, CA1.09MShares$4.56 Million0.27% of portfolio
-
Dimensional Fund Advisors LP Austin, TX658KShares$2.76 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA433KShares$1.82 Million0.0% of portfolio
-
Brandes Investment Partners, LP La Jolla, CA331KShares$1.39 Million0.02% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny328KShares$1.38 Million0.0% of portfolio
-
Dcf Advisers, LLC Greenwich, CT238KShares$998,2000.41% of portfolio
-
Clearline Capital LP New York, NY173KShares$724,8860.03% of portfolio
-
Black Rock Inc. New York, NY148KShares$622,0930.0% of portfolio
-
Geode Capital Management, LLC Boston, MA90.7KShares$380,0790.0% of portfolio
Latest Institutional Activity in LNSR
Top Purchases
Top Sells
About LNSR
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision. The company was incorporated in 2004 and is headquartered in Orlando, Florida.
Insider Transactions at LNSR
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 07
2024
|
Aimee S Weisner |
BUY
Grant, award, or other acquisition
|
Direct |
22,000
+20.45%
|
-
|
|
May 07
2024
|
William J Phd Link |
BUY
Grant, award, or other acquisition
|
Direct |
22,000
+3.89%
|
-
|
|
May 07
2024
|
Thomas B Ellis |
BUY
Grant, award, or other acquisition
|
Direct |
22,000
+41.29%
|
-
|
|
May 07
2024
|
Todd B Hammer |
BUY
Grant, award, or other acquisition
|
Direct |
22,000
+41.29%
|
-
|
|
May 07
2024
|
Richard L Md Lindstrom |
BUY
Grant, award, or other acquisition
|
Direct |
22,000
+8.43%
|
-
|
|
May 07
2024
|
Elizabeth G. O'Farrell |
BUY
Grant, award, or other acquisition
|
Direct |
22,000
+34.07%
|
-
|
|
May 07
2024
|
Gary M Winer |
BUY
Grant, award, or other acquisition
|
Direct |
22,000
+22.6%
|
-
|
|
May 06
2024
|
Nicholas T Curtis Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
71,400
+7.63%
|
-
|
|
May 06
2024
|
Thomas R Staab Ii Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
19,000
+10.68%
|
-
|
|
May 06
2024
|
Kendra Wong Principal Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,200
+28.22%
|
-
|
|
May 06
2024
|
Alan B. Connaughton Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
45,000
+12.18%
|
-
|
|
Jan 11
2024
|
Thomas R Staab Ii Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,853
-1.31%
|
$7,412
$4.43 P/Share
|
|
Jan 11
2024
|
Alan B. Connaughton Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,262
-0.8%
|
$9,048
$4.43 P/Share
|
|
Nov 22
2023
|
Gary M Winer |
BUY
Open market or private purchase
|
Direct |
300
+0.56%
|
$600
$2.1 P/Share
|
|
Nov 16
2023
|
Gary M Winer |
BUY
Open market or private purchase
|
Direct |
1,000
+1.85%
|
$2,000
$2.12 P/Share
|
|
Nov 15
2023
|
Gary M Winer |
BUY
Open market or private purchase
|
Direct |
500
+0.95%
|
$1,000
$2.15 P/Share
|
|
Nov 10
2023
|
Gary M Winer |
BUY
Open market or private purchase
|
Direct |
1,000
+1.9%
|
$2,000
$2.13 P/Share
|
|
Aug 11
2023
|
Gary M Winer |
BUY
Open market or private purchase
|
Direct |
705
+1.38%
|
$2,115
$3.6 P/Share
|
|
Aug 10
2023
|
Gary M Winer |
BUY
Open market or private purchase
|
Direct |
1,000
+1.97%
|
$3,000
$3.66 P/Share
|
|
May 25
2023
|
Todd B Hammer |
BUY
Grant, award, or other acquisition
|
Direct |
9,288
+50.0%
|
-
|
Last 12 Months Summary
| Grant, award, or other acquisition | 304K shares |
|---|---|
| Open market or private purchase | 4.51K shares |
| Payment of exercise price or tax liability | 4.12K shares |
|---|